If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,424.00    -12.00 (-0.84%)
Bid:
1,432.00
Ask:
1,438.00
Spread: 6.00 (0.419%)
Market Cap: £652.62m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Year end and COVID-19 Update

21 May 2020 07:00

RNS Number : 5340N
Cohort PLC
21 May 2020
 

 

 

21 May 2020

 

COHORT PLC

("Cohort" or "the Group")

 

Year end and COVID-19 Update

 

Cohort, the independent technology group, today issues a trading update for its financial year ended 30 April 2020, and an update on its response to COVID-19.

 

Summary:

 

· With the benefit of a lower tax charge we anticipate FY20 earnings per share to be in line with market expectations

· FY20 Revenue expected to be c.£133m (2019: £121.2m)

· FY20 Adjusted* operating profit expected to be c.£18m (2019: £16.2m)

· FY20 Adjusted earnings per share expected to be c.35.0p (2019: 33.6p)

· Net debt at 30 April 2020 of c.£5m (30 April 2019: net debt £6.4m)

· A closing order book of c.£186m (30 April 2019: £190.9m)

· FY21's trading performance difficult to predict given COVID-19 impact but currently expected to be in line with FY20

 

*subject to audit; adjusted figures exclude the effects of marking forward exchange contracts to market value, other exchange gains and losses,

amortisation of other intangible assets and exceptional items.

 

COVID-19 response

 

In responding to the disruption caused by COVID-19, the wellbeing of all our employees remains paramount. The transition to having most employees work from home, and the adoption of social distancing measures for those unable to do so, was achieved quickly and efficiently. Fewer than 30% of the Group's employees are now working on site and many of these are working from home for part or most of the time. Nevertheless, our manufacturing sites have remained operational with enhanced health and safety measures in place.

 

A small minority of Group employees are on furlough leave, most of whom either are vulnerable individuals or have vulnerable dependents. Cost containment and cash preservation measures have been implemented across the Group including Board and senior management pay freezes for the coming financial year.

 

FY20 year end update

 

Cohort's performance was tracking broadly in line with expectations prior to the imposition of COVID-19 restrictions in the last two months of our financial year, typically our busiest period. We were assisted by the UK MOD's quick action to support its suppliers, including faster payments and simplification of some procedures.

 

Nevertheless, the restrictions have affected our ability to carry out work on customer premises and customers' ability to witness acceptance tests and to place new orders. This had some impact on our FY20 revenue and trading profit, although these still showed positive growth compared to FY19. With the benefit of a lower tax charge we anticipate FY20 earnings per share to be in line with market expectations.

 

Despite delays to orders caused by COVID-19 restrictions in the final quarter, order intake for the year was c.£125m, a satisfactory outcome compared to the record order intake of £189.9m in FY19 which included a number of large, long term awards. The expected year end order book of c.£186m is similar to the prior year (2019: £190.9m).

 

As at 30 April 2020, net debt stood at c.£5m (31 October 2019: net debt £6.8m; 30 April 2019: net debt £6.4m); this was better than both our forecast and the position at the last year-end and represents a net debt / EBITDA ratio of less than 0.3 (2019: 0.4).

 

The net debt comprised of gross cash of £20m and gross debt of £25m, together with a £5m undrawn facility, gives the Group access to £25m of available facilities. In addition, the Group has agreed with its banks to convert an existing £10m accordion into a committed facility. This will be used for the proposed acquisition of ELAC, the Germany-based market leader in naval surface ship and submarine sonar systems, that was announced in December 2019.

 

We remain in positive discussions with the German Federal Authorities about approval of the transaction. Both Cohort and Wärtsilä are working hard to complete the transaction in June 2020 as originally planned, but COVID-19 restrictions are likely to result in some delay. We will provide a further update when the conditions for completion have been met.

 

Given the Group's satisfactory performance last year and strong balance sheet, the Board expects to recommend the payment of a final dividend for the year ended 30 April 2020 in line with our progressive policy of recent years. The decision will be announced as usual at the time of the Group's final results and will be subject to shareholder approval at the AGM.

 

FY21 Outlook

 

Cohort remains well placed, having entered the new financial year with a substantial long-term order book. The 30 April 2020 order book of c.£186m underpins nearly £83m (2019: £80m) of current financial year revenue, representing c.60% of expected revenue for the year. The Group has a number of significant new domestic and export opportunities, and extensions to existing contracts, being addressed at Chess, EID and MASS and with good prospects at MCL and SEA.

The potential impact of COVID-19 makes it more difficult than usual to provide guidance. At this early stage the Board expects that restrictions on international travel due to COVID-19 may result in short term constraints on export activity (which represented over 30% of Cohort's revenues in the year just ended). As a result, FY21 trading performance is currently expected to be in line with that achieved in FY20. If appropriate the Board will provide further updates during the current financial year.

In the longer term, the Group expects to return to growth, as it recovers the orders and revenue delayed due to COVID-19.

 

Notice of FY20 results

 

It is the Group's current intention to issue its final results for the year ended 30 April 2020 in July 2020. Given the recent guidance from the FRC around the potential complexity of the audit process under COVID-19 restrictions, the Group will confirm the proposed date in a later announcement.

 

 

Andrew Thomis, Chief Executive of Cohort, said:

"Cohort had a satisfactory year despite the impact of COVID-19 on the business in the last two months of our financial year. We successfully transitioned to most employees working from home, with the adoption of social distancing measures for those unable to do so. We have a robust financial position, a strong order book underpinning 60% of expected current year revenues, and an encouraging pipeline of order opportunities across the business.

 

"Overall, as a result of the impact of COVID-19 we expect trading performance in the coming financial year to be in line with that achieved in 2019/20."

 

 

Ends 

 

For further information, please contact:

 

Cohort plc

 

0118 909 0390

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

 

 

 

 

Investec Bank plc

 

020 7597 5970

Daniel Adams / Chris Baird

 

 

 

 

 

MHP Communications

 

020 3128 8100

Reg Hoare / Pete Lambie / Alice McLaren

 

cohort@mhpc.com

 

NOTES TO EDITORS

Cohort plc (www.cohortplc.com) is the parent company of five innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

Chess Technologies, through its operating businesses Chess Dynamics and Vision4ce, offers systems and technologies for detecting, tracking, classifying and disrupting naval, land and air threats. It was acquired by Cohort plc in December 2018. www.chess-dynamics.com & www.vision4ce.com

EID designs and manufactures advanced communications systems for the defence and security markets. Cohort acquired a majority stake in June 2016. www.eid.pt

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006. www.mass.co.uk

MCL - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007. www.sea.co.uk

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Reading, Berkshire and employs in total around 950 core staff there and at its other operating company sites across the UK and in Portugal.

 

All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which Cohort operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and Cohort's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUGCAUPUGAU
Date   Source Headline
1st Aug 20127:00 amRNSAnnual Financial Report
24th Jul 20127:00 amRNSSEA Awarded £10 million Research Contract
25th Jun 20127:00 amRNSMASS award multi-million pound five-year Contract
25th Jun 20127:00 amRNSFinal Results
24th May 201211:40 amRNSNotice of Results
2nd May 201211:31 amRNSHolding(s) in Company
6th Jan 20127:00 amRNSDoc re Interim Report
15th Dec 20117:00 amRNSHalf Yearly Report
5th Dec 20117:00 amRNSFurther ECS Work for SEA and Trading Update
16th Nov 20117:00 amRNSNotice of Results
2nd Sep 201110:38 amRNSResult of AGM
3rd Aug 20114:30 pmRNSDirector/PDMR Shareholding
29th Jul 20117:00 amRNSAnnual Financial Report
27th Jun 20117:00 amRNSMASS Contract Win
27th Jun 20117:00 amRNSFinal Results
2nd Jun 20111:37 pmRNSNotice of Results
30th Mar 20117:00 amRNSSCS Wins £5.8 million Training Services Contract
2nd Feb 20115:02 pmRNSHolding(s) in Company
24th Jan 20117:00 amRNSAppointment of New Managing Director at SEA
7th Jan 20118:55 amRNSDoc re Interim Report
16th Dec 20107:00 amRNSHalf Yearly Report
1st Dec 20108:48 amRNSEmployee Benefit Trust Purchase
22nd Nov 20105:17 pmRNSDirector/PDMR Shareholding
27th Oct 20107:00 amRNSContract and Trading Update
27th Oct 20107:00 amRNSContract and Trading Update
21st Oct 20105:12 pmRNSDoc re. Annual Report
21st Oct 20105:12 pmRNSDoc re. Annual Report
20th Oct 20103:36 pmRNSHolding(s) in Company
20th Oct 20103:36 pmRNSHolding(s) in Company
18th Oct 20107:00 amRNSContract Win
3rd Sep 20108:37 amRNSResult of AGM
29th Jul 20104:16 pmRNSDirector/PDMR Shareholding
15th Jul 201012:29 pmRNSSEA Wins ?3.5million contract
28th Jun 20107:00 amRNSAppointment of new SCS Managing Director
28th Jun 20107:00 amRNSFinal Results
26th May 20101:38 pmRNSNotice of Results
17th May 20107:00 amRNSAcquisition of Abacus EW Consultancy Ltd
13th Apr 20107:00 amRNSOver ?60m new contract wins
18th Mar 20107:00 amRNSBusiness and Trading Update
18th Dec 200912:49 pmRNSDirector/PDMR Shareholding
17th Dec 20095:01 pmRNSDirector/PDMR Shareholding
17th Dec 20094:52 pmRNSDirector/PDMR Shareholding
17th Dec 20094:49 pmRNSDirector/PDMR Shareholding
17th Dec 20094:45 pmRNSDirector/PDMR Shareholding
15th Dec 20095:03 pmRNSHolding(s) in Company
15th Dec 20095:01 pmRNSHolding(s) in Company
9th Dec 20093:16 pmRNSInterim Results - Amendment
9th Dec 20097:00 amRNSHalf Yearly Report
3rd Dec 20092:52 pmRNSStatement re Trading at SCS Ltd
1st Dec 20091:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.